Paediatric obesities: From childhood to adolescence;Obesidades pediátricas: de la lactancia a la adolescencia

Anales de Pediatria

Volumn 75, Issue 1, 2011, Pages

  Martos Moreno, G A ^a   Argente, J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Childhood obesity; Comorbidities; Monogenic; Obesity management; Polygenic; Syndromic

Indexed keywords

ADOLESCENCE; ARTICLE; CALORIC INTAKE; CHILD DEVELOPMENT; CHILDHOOD; CLINICAL FEATURE; DIAGNOSTIC TEST; ENERGY EXPENDITURE; FAMILY HISTORY; GENETIC RISK; HUMAN; OBESITY; PATHOPHYSIOLOGY; PEDIATRICIAN; PEDIATRICS; PHYSICAL EXAMINATION; PREVALENCE; SPAIN;

ADOLESCENT; CHILD; HUMANS; OBESITY;

EID: 79959474939     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2011.03.018     Document Type: Article

References (160)

1. J.C. Wells, and M.S. Fewtrell Measuring body composition Arch Dis Child 91 2006 612 617 (Pubitemid 44023365)
2. E.S. Weigley Adolphe Quetelet Am J Clin Nutr 71 2000 853
3. D.S. Freedman, L.K. Khan, M.K. Serdula, W.H. Dietz, S.R. Srinivasan, and G.S. Berenson Inter-relationships among childhood BMI, childhood height, and adult obesity: the Bogalusa Heart Study Int J Obes Relat Metab Disord 28 2004 10 16 (Pubitemid 38141984)
4. Martos-Moreno GÁ, V. Barrios, G. Martínez, F. Hawkins, and J. Argente Effect of weight loss on high-molecular weight adiponectin in obese children Obesity 18 2010 2288 2294
5. P.W. Speiser, M.C. Rudolf, H. Anhalt, C. Camacho-Hubner, F. Chiarelli, and A. Eliakim Consensus statement: Childhood obesity J Clin Endocrinol Metab 90 2005 1871 1887 (Pubitemid 40464063)
6. C.L. Ogden, S.Z. Yanovski, M.D. Carroll, and K.M. Flegal The epidemiology of obesity Gastroenterology 132 2007 2087 2102 (Pubitemid 46693751)
7. T.J. Cole, M.C. Bellizzi, K.M. Flegal, and W.H. Dietz Establishing a standard definition for child overweight and obesity worldwide: international survey BMJ 320 2000 1240 1243 (Pubitemid 30240471)
8. M.C. Bellizzi, and W.H. Dietz Workshop on childhood obesity: summary of the discussion Am J Clin Nutr 70 1999 173S 175S (Pubitemid 29461136)
9. National Center for Health Statistics. Health, United States, 2006. With Chartbook on Trends in the Health of Americans. Hyattsville: 2006; Library of Congress, Catalog Number 76-641496. p. 482.
10. Grupo de trabajo de la guía sobre la prevención y el tratamiento de la obesidad infantojuvenil. Centro Cochrane Iberoamericano, coordinador. Guía de práctica clínica sobre la prevención y el tratamiento de la obesidad infantojuvenil. Madrid: Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social. Agncia dAvaluació de Tecnologia i Recerca Mdiques; 2009. Guía de práctica clínica: AATRM N.° 2007/25.
11. J. Argente, G.A. Martos-Moreno, J.C. Buñuel, P. Alonso-Coello, and S. Tort Guía de práctica clínica sobre la prevención y el tratamiento de la obesidad infantojuvenil: Parte I: Definición y Prevención Rev Esp Ped 66 2010 329 336
12. M. Hernández, J. Castellet, J.L. Narvaíza, J.M. Rincón, I. Ruiz, and E. Sánchez M. Hernández, F. Fundación, Orbegozo Curvas y tablas de crecimiento 1988 Editorial Garsi Madrid
13. D.S. Freedman, J. Wang, L.M. Maynard, J.C. Thornton, Z. Mei, and R.N. Pierson Relation of BMI to fat and fat-free mass among children and adolescents Int J Obes (Lond) 29 2005 1 8 (Pubitemid 40065459)
14. J.J. Reilly Descriptive epidemiology and health consequences of childhood obesity Best Pract Res Clin Endocrinol Metab 19 2005 327 341 (Pubitemid 41263790)
15. M. De Onis, and M. Blossner The World Health Organization global database on child growth and malnutrition: methodology and applications Int J Epidemiol 32 2003 518 526 (Pubitemid 37039002)
16. Paidos '84. Estudio epidemiológico sobre nutrición y obesidad infantil. Madrid: Jofamar; 1985.
17. Grupo colaborativo español para el estudio de los Factores de riesgo Cardiovascular en la Infancia y adolescencia. Factores de riesgo cardiovascular en la infancia y adolescencia en España. Estudio Ricardin II: valores de referencia. An Pediatr (Barc). 1995;43:11-7.
18. R. Elcarte, I. Villa-Elízaga, J. Sada, M. Gasco, M. Oyarzábal, and A. Sola Estudio de Navarra (PECNA). Prevalencia de hipertensión arterial, hiperlipidemia y obesidad en la población infanto-juvenil de Navarra. Asociación de estos factores de riesgo Acta Pediatr Esp 38 1993 428 436
19. L. Serra Majem, L. Ribas Barba, J. Aranceta Bartrina, C. Perez Rodrigo, P. Saavedra Santana, and L. Pena Quintana Childhood and adolescent obesity in Spain. Results of the enKid study (1998-2000) Med Clin (Barc) 121 2003 725 732 (Pubitemid 38063433)
20. L.A. Moreno, M.I. Mesana, J. Fleta, J.R. Ruiz, M. González-Gross, A. Sarriá AVENA Study Group Overweight, obesity and body fat composition in Spanish adolescents. The AVENA Study Ann Nutr Metab 49 2005 71 76 (Pubitemid 40827626)
21. Encuesta Nacional de Salud de España 2006. Ministerio de Sanidad y Consumo. Gobierno de España. Disponible en: http://www.msc.es/ estadEstudios/estadisticas/encuestaNacional /encuesta2006.htm.
22. Agencia Española de Seguridad Alimentaria. Estrategia NAOS para la nutrición, actividad física y prevención de la obesidad. Disponible en: http://www.aesa.msc.es/aesa/web/AesaPageServer?idpage= 9&idcontent=5672.
23. G.A. Martos-Moreno, J. Argente, J.C. Buñuel, S. Tort, and P. Alonso-Coello Guía de práctica clínica sobre la prevención y el tratamiento de la obesidad infantojuvenil: Parte II: Tratamiento Rev Esp Ped 66 2010 337 343
24. D. Samani-Radia, and H.D. McCarthy Comparison of children's body fatness between two contrasting income groups: contribution of height difference Int J Obes 35 2011 128 133
25. V. Svensson, J.A. Jacobsson, R. Fredriksson, P. Danielsson, T. Sobko, and H.B. Schiöth Associations between severity of obesity in childhood and adolescence, obesity onset and parental BMI: a longitudinal cohort study Int J Obes 35 2011 46 52
26. G. Pare Genome-wide association Studies -data generation, storage, interpretation, and bioinformatics J Cardiovasc Transl Res 3 2010 183 188
27. T. Rankinen, A. Zuberi, Y.C. Chagnon, S.J. Weisnagel, G. Argyropoulos, and B. Walts The human obesity gene map: the 2005 update Obesity (Silver Spring) 14 2006 529 644 (Pubitemid 46219737)
28. K.A. Lillycrop, and G.C. Burdge Epigenetic changes in early life and future risk of obesity Int J Obes 35 2011 72 83
29. A. Scuteri, S. Sanna, W.M. Chen, M. Uda, G. Albai, and J. Strait Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits PLoS Genet 3 2007 1200 1210 (Pubitemid 47203970)
30. T.M. Frayling, N.J. Timpson, M.N. Weedon, E. Zeggini, R.M. Freathy, and C.M. Lindgren A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity Science 316 2007 889 894 (Pubitemid 46764279)
31. D. Meyre, J. Delplanque, J.C. Chvre, C. Lecoeur, S. Lobbens, and S. Gallina Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations Nat Genet 41 2009 157 159
32. J.E. Cecil, R. Tavendale, P. Watt, M.M. Hetherington, and C.A.N. Palmer An Obesity-Associated FTO Gene Variant and Increased Energy Intake in Children N Engl J Med 359 2008 2558 2566
33. I. Labayen, J.R. Ruiz, F.B. Ortega, J. Dalongeville, D. Jiménez-Pavón, and M.J. Castillo Association between the FTO rs9939609 polymorphism and leptin in European adolescents: a possible link with energy balance control. The HELENA study Int J Obes 35 2011 66 71
34. J. Fischer, L. Koch, C. Emmerling, J. Vierkotten, T. Peters, and J.C. Brüning Inactivation of the Fto gene protects from obesity Nature 458 2009 894 898
35. A. Hinney, C.I. Vogel, and J. Hebebrand From monogenic to polygenic obesity: recent advances Eur Child Adolesc Psychiatry 19 2010 297 310
36. M. Hofker, and C. Wijmenga A supersized list of obesity genes Nat Genet 41 2009 139 140
37. E.G. Bochukova, N. Huang, J. Keogh, E. Henning, C. Purmann, and K. Blaszczyk Large, rare chromosomal deletions associated with severe early-onset obesity Nature 463 2010 666 670
38. Martos-Moreno GÁ, V. Barrios, and J. Argente Mecanismos reguladores del metabolismo energético An Pediatr 64Supl2 2006 53 58
39. A.P. Coll, I.S. Farooqi, and S. O'Rahilly The hormonal control of food intake Cell 129 2007 251 262 (Pubitemid 46574977)
40. C.T. Montague, I.S. Farooqi, J.P. Whitehead, M.A. Soos, H. Rau, and N.J. Wareham Congenital leptin deficiency is associated with severe early-onset obesity in humans Nature 387 1997 903 908 (Pubitemid 27289591)
41. I.S. Farooqi, G. Matarese, G.M. Lord, J.M. Keogh, E. Lawrence, and C. Agwu Beneficial effects of leptin on obesity. T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency J Clin Invest 110 2002 1093 1103 (Pubitemid 35215890)
42. W.T. Gibson, I.S. Farooqi, M. Moreau, A.M. DePaoli, E. Lawrence, and S. O'Rahilly Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy J Clin Endocrinol Metab 89 2004 4821 4826 (Pubitemid 39391413)
43. G.A. Martos-Moreno, J.A. Chowen, and J. Argente Metabolic signals in human puberty: effects of over and undernutrition Mol Cell Endocrinol 324 2010 70 81
44. K. Clement, C. Vaisse, N. Lahlou, S. Cabrol, V. Pelloux, and D. Cassuto A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction Nature 392 1998 398 401 (Pubitemid 28168737)
45. I.S. Farooqi, T. Wangensteen, S. Collins, W. Kimber, G. Matarese, and J.M. Keogh Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor N Engl J Med 356 2007 237 247 (Pubitemid 46143227)
46. H. Krude, H. Biebermann, W. Luck, R. Horn, G. Brabant, and A. Grüters Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans Nat Genet 19 1998 155 157 (Pubitemid 28248796)
47. H. Krude, H. Biebermann, D. Schnabel, M.Z. Tansek, P. Theunissen, and P.E. Mullis Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10 J Clin Endocrinol Metab 88 2003 4633 4640 (Pubitemid 37357504)
48. I.S. Farooqi, S. Drop, A. Clements, J.M. Keogh, J. Biernacka, and S. Lowenbein Heterozigosity for a POMC-null mutation and increased obesity risk in humans Diabetes 55 2006 2549 2553 (Pubitemid 44871155)
49. R.S. Jackson, J.W. Creemers, S. Ohagi, M.L. Raffin-Sanson, L. Sanders, and C.T. Montague Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene Nat Genet 16 1997 303 306 (Pubitemid 27280217)
50. R.S. Jackson, J.W. Creemers, I.S. Farooqi, M.L. Raffin-Sanson, A. Varro, and G.J. Dockray Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency J Clin Invest 112 2003 1550 1560 (Pubitemid 38056281)
51. I.S. Farooqi, K. Volders, R. Stanhope, R. Heuschkel, A. White, and E. Lank Hyperphagia and early-onset obesity due to a novel homozygous missence mutation in prohormone convertase 1/3 J Clin Endocrinol Metab 92 2007 3369 3373 (Pubitemid 47435306)
52. C. Vaisse, K. Clement, B. Guy-Grand, and P. Froguel A frameshift mutation in human MC4R is associated with a dominant form of obesity Nat Genet 20 1998 113 114 (Pubitemid 28455439)
53. G.S. Yeo, I.S. Farooqi, S. Aminian, D.J. Halsall, R.G. Stanhope, and S. O'Rahilly A frameshift mutation in MC4R associated with dominantly inherited human obesity Nat Genet 20 1998 111 112 (Pubitemid 28455438)
54. I.S. Farooqi, J.M. Keogh, G.S. Yeo, E.J. Lank, T. Cheetham, and S. O'Rahilly Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene N Engl J Med 348 2003 1085 1095 (Pubitemid 36337319)
55. C. Lubrano-Berthelier, B. Dubern, J.M. Lacorte, F. Picard, A. Shapiro, and S. Zhang Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating J Clin Endocrinol Metab 91 2006 1811 1818
56. P. René, C. Le Gouill, I.D. Pogozheva, H.I. Mosberg, I.S. Farooqi, and K.J. Valenzano Pharmacological chaperones restore function to MC4R mutants responsable for severe early-onset obesity J Pharmacol Exp Ther 335 2010 520 532
57. M. Ristow, D. Muller-Wieland, A. Pfeiffer, W. Krone, and C.R. Kahn Obesity associated with a mutation in a genetic regulator of adipocyte differentiation New Eng J Med 339 1998 953 959 (Pubitemid 28455097)
58. D.B. Savage, M. Agostini, I. Barroso, M. Gurnell, J. Luan, and A. Meirhaeghe Digenic inheritance of severe insulin resistance in a human pedigree Nature Genet 31 2002 379 384 (Pubitemid 35154446)
59. J.L. Holder Jr., N.F. Butte, and A.R. Zinn Profound obesity associated with a balanced translocation that disrupts the SIM1 gene Hum Mol Genet 9 2000 101 108 (Pubitemid 30145294)
60. B.M. Kublaoui, J.L. Holder Jr., T. Gemelli, and A.R. Zinn Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons Mol Endocrinol 20 2006 2483 2492 (Pubitemid 44496416)
61. K.P. Tolson, T. Gemelli, L. Gautron, J.K. Elmquist, A.R. Zinn, and B.M. Kublaoui Postnatal Sim1 deficiency causes hyperphagic obesity and reduced Mc4r and oxytocin expression Neurobiol Dis 30 2010 3803 3812
62. N. Ahituv, N. Kavaslar, W. Schackwitz, A. Ustaszewska, J. Martin, and S. Hebert Medical sequencing at the extremes of human body mass Am J Hum Genet 80 2007 779 791 (Pubitemid 46564414)
63. J. Keogh, E. Henning, S. Ramachandrappa, E. Bochukova, S. Saeed, and S. O'Rahilly SIM1 (single-minded 1) mutations associated with severe childhood obesity Horm Res Ped 74 Suppl 3 2010 FC223 FC282
64. C. Wentzel, S.A. Lynch, F.H. Stattin, G. Annerén, and A.C. Thuresson Interstitial deletions at 6q14.1-q15 associated with obesity, developmental delay and a distinct clinical phenotype Mol Syndromol 1 2010 75 81
65. L. Tapia-Arancibia, F. Rage, L. Givalois, and S. Arancibia Physiology of BDNF: focus on hypothalamic function Front Neuroendocrinol 25 2004 77 107 (Pubitemid 39582717)
66. E.E. Noble, C. Billington, C.M. Kotz, and C. Wang The lighter side of BDNF Am J Physiol 2011 10.1152/ajpregu.00776.2010
67. J. Gray, G.S. Yeo, J.J. Cox, J. Morton, A.L.R. Adlam, and J.M. Keogh Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene Diabetes 55 2006 3366 3371 (Pubitemid 44923594)
68. G.S. Yeo, C.C. Connie Hung, J. Rochford, J. Keogh, J. Gray, and S. Sivaramakrishnan A de novo mutation affecting human TrkB associated with severe obesity and developmental delay Nat Neurosci 7 2004 1187 1189 (Pubitemid 39426236)
69. J.C. Han, Q.R. Liu, M. Jones, R.L. Levinn, C.M. Menzie, and K.S. Jefferson-George Brain-derived neurotrophic factor and obesity in the WAGR syndrome N Engl J Med 359 2008 918 927
70. C.G. Bell, A.J. Walley, and P. Froguel The genetics of human obesity Nat Rev Genet 6 2005 221 234 (Pubitemid 40293032)
71. A.P. Goldstone, A.J. Holland, B.P. Hauffa, A.C. Hokken-Koelega, M. Tauber speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS Recommendations for the diagnosis and management of Prader-Willi syndrome J Clin Endocrinol Metab 93 2008 4183 4197 (Pubitemid 352789509)
72. T. Sahoo, D. Del Gaudio, J.R. German, M. Shinawi, S.U. Peters, and R.E. Person Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster Nat Genet 40 2008 719 721 (Pubitemid 351748873)
73. M. Scerif, A.P. Goldstone, and M. Korbonits Ghrelin in obesity and endocrine diseases Mol Cell Endocrinol 2011 10.1016/j.m.c.2011.02.011
74. L. Abu Safieh, M. Aldahmesh, H. Shamseldin, M. Hashem, R. Shaheen, and H. Alkuraya Clinical and molecular characterization of Bardet-Biedl syndrome in consanguineous populations: The power of homozygosity mapping J Med Genet 47 2010 236 241
75. S.J. Moore, J.S. Green, Y. Fan, A.K. Bhogal, E. Dicks, and B.A. Fernandez Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study Am J Med Genet 132A 2005 352 360 (Pubitemid 40175583)
76. A. Verloes, I.K. Temple, S. Bonnet, and A. Bottani Coloboma, mental retardation, hypogonadism, and obesity: critical review of the so-called Biemond syndrome type 2, updated nosology, and delineation of three 'new' syndromes Am J Med Genet 69 1997 370 379
77. S.K. Kim, A. Shindo, T.J. Park, E.C. Oh, S. Ghosh, and R.S. Gray Planar cell polarity acts through septins to control collective cell movement and ciliogenesis Science 329 2010 1337 1340
78. J.R. Davenport, A.J. Watts, V.C. Roper, M.J. Croyle, T. Van Groen, and J.M. Wyss Disruption of intraflagellar transport in adult mice leads to obesity ans slow-onset cystic kidney disease Curr Biol 17 2007 1586 1594 (Pubitemid 47380400)
79. G. Li, R. Vega, K. Neims, N. Gekakis, C. Goodnow, and P. McNamara A role for Alsmtröm syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence PLOs Genet 3 2007 9 20
80. S. Yoshimura, J. Egerer, E. Fuchs, A.K. Haas, and F.A. Barr Functional dissection of RabGTPases involved in primary cilium formation J Cell Biol 178 2007 363 369 (Pubitemid 47196146)
81. G.A. Martos-Moreno, V. Barrios, and J. Argente Fundamentos clínico-diagnósticos y estrategias terapéuticas en la obesidad infantil Rev Esp Ped 65 2009 408 422
82. S. Ten, and N. Maclaren Insulin resistance syndrome in children J Clin Endocrinol Metab 89 2004 2526 2539 (Pubitemid 38766328)
83. G.M. Reaven Banting lecture 1988. Role of insulin resistance in human disease Diabetes 37 1988 1595 1607 (Pubitemid 19004941)
84. M.T. Muñoz-Calvo, and J. Argente Síndrome metabólico Rev Esp Ped 65 2009 423 432
85. Moya M. Estados comórbidos de la obesidad pediátrica y del adolescente. Un enfoque facilitador de su diagnóstico: el síndrome metabólico. An Pediatr. 2011. En prensa.
86. K. Alberti, and P. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553 (Pubitemid 28319935)
87. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
88. K.G. Alberti, P. Zimmet, J. Shaw IDF Epidemiology Task Force Consensus Group The metabolic syndrome -a new worldwide definition Lancet 366 2005 1059 1062 (Pubitemid 41338752)
89. E. Goodman, S.R. Daniels, J.B. Meigs, and L.M. Dolan Instability in the diagnosis of metabolic syndrome in adolescents Circulation 115 2007 2316 2322 (Pubitemid 46691226)
90. K.L. Jones The dilemma of the metabolic syndrome in children and adolescents: disease or distraction? Pediatr Diabetes 7 2006 311 321 (Pubitemid 44921104)
91. J. Steinberger Diagnosis of the metabolic syndrome in children Curr Opin Lipidol 14 2003 555 559 (Pubitemid 41623183)
92. R. Weiss, J. Dziura, T.S. Burgert, W.V. Tamborlane, S.E. Taksali, and C.W. Yeckel Obesity and the metabolic syndrome in children and adolescents N Engl J Med 350 2004 2362 2374 (Pubitemid 38702847)
93. G.S. Berenson, W.A. Wattigney, R.E. Tracy, W.P. Newman 3rd., S.R. Srinivasan, and L.S. Webber Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study) Am J Cardiol 70 1992 851 858
94. P. Zimmet, G. Alberti, F. Kaufman, N. Tajima, M. Silink, and S. Arslanian International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes. The metabolic syndrome in children and adolescents -an IDF consensus report Lancet 369 2007 2059 2061
95. Barrios V, Martos-Moreno GA, Frago L, Chowen JA, Argente J. Neuroendocrine regulation. En: Moreno L, Pigeot I, Ahrens W, editores. Epidemiology of obesity in children and adolescents (Book I of II): prevalence and aetiology. Springer series «Epidemiology and public health». 2011. En prensa.
96. L. Soriano-Guillén, V. Barrios, J.A. Chowen, I. Sánchez, S. Vila, J. Quero, and J. Argente Ghrelin levels from fetal life through early adulthood: relationship with endocrine and metabolic and anthropometric measures J Pediatr 144 2004 30 35 (Pubitemid 38091418)
97. G.A. Martos-Moreno, V. Barrios, M. Sáenz de Pipaón, J. Pozo, I. Dorronsoro, and M. Martínez-Biarge Influence of prematurity and growth restriction on the adipokine profile. IGF1, and ghrelin levels in cord blood: relationship with glucose metabolism Eur J Endocrinol 161 2009 381 389
98. G.A. Martos-Moreno, V. Barrios, and J. Argente Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids Eur J Endocrinol 155 2006 429 434 (Pubitemid 44463949)
99. L. Soriano-Guillén, V. Barrios, G. Martos, J.A. Chowen, A. Campos-Barros, and J. Argente Effect of oral glucose administration on ghrelin levels in obese children Eur J Endocrinol 151 2004 119 121 (Pubitemid 39117373)
100. J. Argente, V. Barrios, J.A. Chowen, M.K. Sinha, and R.V. Considine Leptin plasma levels in healthy Spanish children and adolescents, children with obesity, and adolescents with anorexia nervosa and bulimia nervosa J Pediatr 131 1997 833 838 (Pubitemid 28027606)
101. G.A. Martos-Moreno, V. Barrios, G. Martínez, F. Hawkins, and J. Argente Acylated ghrelin levels in prepubertal obese children at diagnosis and after weight reduction; effect of oral glucose ingestion J Endocrinol Invest 34 2011 117 123
102. G.A. Martos-Moreno, J. Kratzsch, A. Körner, V. Barrios, F. Hawkins, and W. Kiess Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism Int J Obes (Lond) 2011
103. M.D. Jensen Role of body fat distribution and the metabolic complications of obesity J Clin Endocrinol Metab 93 2008 S57 63
104. J.R. Fernández, D.T. Redden, A. Pietrobelli, and D.B. Allison Waist circumference percentiles in nationally representative samples of African-American. European-American, and Mexican-American children and adolescents J Pediatr 145 2004 439 444 (Pubitemid 39345977)
105. W. Shen, H. Liu, M. Punyanitya, J. Chen, and S.B. Heymsfield Pediatric obesity phenotyping by magnetic resonance methods Curr Opin Clin Nutr Metab Care 8 2005 595 601 (Pubitemid 41585998)
106. Barlow SE; comittee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120:S164-92.
107. S.R. Daniels, M.S. Jacobson, B.W. McCrindle, R.H. Eckel, and B.M. Sanner American Heart Association Childhood Obesity Research Summit Report Circulation 119 2009 e489 517
108. A.M. Cali, and S. Caprio Obesity in children and adolescents J Clin Endocrinol Metab 93 2008 S31 36
109. J.P. McClung, and J.P. Karl Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption Nutr Rev 67 2009 100 104
110. American Diabetes Association Standards of Medical Care in Diabetes-2011 Diabetes Care 34 2011 S11 61
111. N.F. Krebs, J.H. Himes, D. Jacobson, T.A. Nicklas, P. Guilday, and D. Styne Assessment of child and adolescent overweight and obesity Pediatrics 120 2007 S193 228
112. K.J. Campbell, and K.D. Hesketh Strategies which aim to positively impact on weight, physical activity, diet and sedentary behaviours in children from zero to five years. A systematic review of the literature Obes Rev 8 2007 327 338 (Pubitemid 46944493)
113. Scottish Intercollegiate Guidelines Network. Management of Obesity. A national clinical guideline 2010.
114. C.E. Collins, J.M. Warren, M. Neve, P. McCoy, and B. Stokes Systematic review of interventions in the management of overweight and obese children which include a dietary component Int J EB Healthcare 5 2007 2 53
115. Oude Luttikhuis H, Baur L, Jansen H, Shrewsbury VA, O'Malley C, Stolk RP, et al. Interventions for treating obesity in children. Cochrane Database Syst Rev. 2009:CD001872.
116. M.P. Kalavainen, M.O. Korppi, and O.M. Nuutinen Clinical efficacy of group-based treatment for childhood obesity compared with routinely given individual counseling Int J Obes (Lond) 31 2007 1500 1508 (Pubitemid 47482651)
117. K. Steinbeck Childhood obesity. Treatment options Best Pract Res Clin Endocrinol Metab 19 2005 455 469
118. T.A. Wadden, and M.L. Butryn Behavioral treatment of obesity Endocrinol Metab Clin North Am 32 2003 981 1003 (Pubitemid 38029990)
119. G.D. Foster, A.P. Makris, and B.A. Bailer Behavioral treatment of obesity Am J Clin Nutr 82Suppl1 2005 230S 235S
120. R.K. Golley, A.M. Magarey, L.A. Baur, K.S. Steinbeck, and L.A. Daniels Twelve-month effectiveness of a parent-led, family-focused weight-management program for prepubertal children: a randomized, controlled trial Pediatrics 119 2007 517 525 (Pubitemid 46407521)
121. L.J. Gibson, J. Peto, J.M. Warren, and I. Dos Santos Silva Lack of evidence on diets for obesity for children: a systematic review Int J Epidemiol 35 2006 1544 1552 (Pubitemid 46178933)
122. N.F. Krebs, D. Gao, J. Gralla, J.S. Collins, and S.L. Johnson Efficacy and safety of a high protein, low carbohydrate diet for weight loss in severely obese adolescents J Pediatr 157 2010 252 258
123. E.H. Kossoff, B.A. Zupec-Kania, P.E. Amark, K.R. Ballaban-Gil, A.G. Christina Bergqvist, R. Blackford Charlie Foundation, Practice Committee of the Child Neurology Society; Practice Committee of the Child Neurology Society; International Ketogenic Diet Study Group Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group Epilepsia 50 2009 304 317
124. B. Wüthrich Unproven techniques in allergy diagnosis J Investig Allergol Clin Immunol 15 2005 86 90 (Pubitemid 41020168)
125. J. Dalmau Serra, M. Alonso Franch, L. Gómez López, C. Martínez Costa, and C. Sierra Salinas Childhood obesity. Recomendaciones del Comité de Nutrición de la Asociación Española de Pediatría. Parte II. Diagnóstico. Comorbilidades. Tratamiento An Pediatr (Barc) 66 2007 294 304
126. L.H. Epstein, R.R. Wing, and A. Valoski Childhood obesity Pediatr Clin North Am 32 1985 363 379 (Pubitemid 15056441)
127. O. Bar-Or, J. Foreyt, C. Bouchard, K.D. Brownell, W.H. Dietz, and E. Ravussin Physical activity, genetic, and nutritional considerations in childhood weight management Med Sci Sports Exerc 30 1998 2 10 (Pubitemid 28071377)
128. P. Brambilla, G. Pozzobon, and A. Pietrobelli Physical activity as the main therapeutic tool for metabolic syndrome in childhood Int J Obes 35 2011 16 28
129. K. Watts, T.W. Jones, E.A. Davis, and D. Green Exercise training in obese children and adolescents Sports Med 35 2005 375 392 (Pubitemid 40806939)
130. M.H. Park, S. Kinra, K.J. Ward, B. White, and R.M. Viner Metformin for obesity in children and adolescents: a systematic review Diabetes Care 32 2009 1743 1745
131. S.M. Quinn, L.A. Baur, S.P. Garnett, and C.T. Cowell Treatment of clinical insulin resistance in children: a systematic review Obes Rev 11 2010 722 730
132. B. Ozkan, A. Bereket, S. Turan, and S. Keskin Addition of orlistat to conventional treatment in adolescents with severe obesity Eur J Pediatr 163 2004 738 741 (Pubitemid 40064382)
133. J.P. Chanoine, S. Hampl, C. Jensen, M. Boldrin, and J. Hauptman Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial JAMA 293 2005 2873 2883 (Pubitemid 41029141)
134. D. Maahs, D.G. De Serna, R.L. Kolotkin, S. Ralston, J. Sandate, and C. Qualls Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents Endocr Pract 12 2006 18 28
135. S. Norgren, P. Danielsson, R. Jurold, M. Lötborn, and C. Marcus Orlistat treatment in obese prepubertal children: a pilot study Acta Paediatr 92 2003 666 670 (Pubitemid 37088673)
136. S. Czernichow, C.M. Lee, F. Barzi, J.R. Greenfield, L.A. Baur, and J. Chalmers Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials Obes Rev 11 2010 150 158
137. T.H. Inge, N.F. Krebs, V.F. Garcia, J.A. Skelton, K.S. Guice, and R.S. Strauss Bariatric surgery for severely overweight adolescents: concerns and recommendations Pediatrics 114 2004 217 223 (Pubitemid 38857589)
138. M.L. Lawson, S. Kirk, T. Mitchell, M.K. Chen, T.J. Loux, S.R. Daniels Pediatric Bariatric Study Group One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group J Pediatr Surg 41 2006 137 143 (Pubitemid 43067507)
139. G.A. Fielding, and J.E. Duncombe Laparoscopic adjustable gastric banding in severely obese adolescents Surg Obes Relat Dis 1 2005 399 405
140. Fernandes M, Atallah AN, Soares BGO, Humberto S, Guimarães S, Matos D, et al. Balón intragástrico. Cochrane Database Syst Rev. 2007;(1):CD004931.
141. Y. Vandenplas, P. Bollen, K. De Langhe, K. Vandemaele, and J. De Schepper Intragastric balloons in adolescents with morbid obesity Eur J Gastroenterol Hepatol 11 1999 243 245 (Pubitemid 29286676)
142. M. Hallschmid, R. Smolnik, G. McGregor, J. Born, and H.L. Fehm Overweight humans are resistant to the weight-reducing effects of melanocortin 4-10 J Clin Endocrinol Metab 91 2006 522 555
143. J.E. Wikberg, and F. Mutulis Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction Nat Rev Drug Discov 7 2008 307 323
144. R.F. Witkamp Current and Future Drug Targets in Weight Management Pharm Res 2011 10.1007/s11095-010-0341-1
145. Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: past, current, and future therapies. J Obes. 2011;ID: 179674.
146. Iughetti L, China M, Berri R, Predieri B. Pharmacological treatment of obesity in children and adolescents: present and future. J Obes. 2011;ID: 928165.
147. L. Van Gaal, F. Vercruysse, E. Wajs, J. Xie, D. Ways, and L. Van Nueten JNJ-16269110, an enterically targetted microsomal triglyceride transfer protein inhibitor, lowers body weight in overweight/obese subjects Obes Rev 11 Suppl s1 2010 42
148. N. Salomé, C. Hansson, M. Taube, L. Gustafsson-Ericson, E. Egecioglu, and L. Karlsson-Lindahl On the central mechanism underlying ghrelin's chronic pro-obesity effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist J Neuroendocrinol 21 2009 777 785
149. S. Helmling, C. Maasch, D. Eulberg, K. Buchner, W. Schröder, and C. Lange Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer Proc Natl Acad Sci USA 101 2004 1374 1379
150. J.A. Vizcarra, J.D. Kirby, S.K. Kim, and M.L. Galyean Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs Domest Anim Endocrinol 33 2007 176 189 (Pubitemid 47016890)
151. F.L. Greenway, K. Fujioka, R.A. Plodkowski, S. Mudaliar, M. Guttadauria, J. Erickson COR-I Study Group Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Lancet 376 2010 595 605
152. H. Bays Phentermine, topiramate and their combination for the treatment of adiposopathy («sick fat») and metabolic disease Expert Rev Cardiovasc Ther 8 2010 1777 1801
153. C. Addy, S. Li, N. Agrawal, J. Stone, A. Majumdar, and L. Zhong Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers J Clin Pharmacol 48 2008 418 427 (Pubitemid 351389116)
154. B. Xu, M.G. Dube, P.S. Kalra, W.G. Farmerie, A. Kaibara, and L.L. Moldawer Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin Endocrinology 139 1998 466 473 (Pubitemid 28513190)
155. P.D. Lambert, K.D. Anderson, M.W. Sleeman, V. Wong, J. Tan, and A. Hijarunguru Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity Proc Natl Acad Sci U S A 98 2001 4652 4657 (Pubitemid 32295031)
156. F.M. Ng, J. Sun, L. Sharma, R. Libinaka, W.J. Jiang, and R. Gianello Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone Horm Res 53 2000 274 278 (Pubitemid 32037592)
157. J.L. Méndez-Andino, and J.A. Wos MCH-R1 antagonists: what is keeping most research programs away from the clinic? Drug Discov Today 12 2007 972 979 (Pubitemid 350052673)
158. B. Bai, and Y. Wang The use of lorcaserin in the management of obesity: a critical appraisal Drug Des Devel Ther 5 2010 1 7
159. D.J. Heal, S.L. Smith, A. Fisas, X. Codony, and H. Buschmann Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders Pharmacol Ther 117 2008 207 231
160. K.A. Anderson, T.J. Ribar, F. Lin, P.K. Noeldner, M.F. Green, and M.J. Muehlbauer Hypothalamic CaMKK2 contributes to the regulation of energy balance Cell Metab 7 2008 377 388 (Pubitemid 351598022)